IDEX Corporation (IEX) Q4 2025 Earnings Call Transcript
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
Overview
The earnings call presents a mixed outlook. While there is strong performance in HST and optimistic guidance for 2026, there are concerns about flat volumes, pressures in FSDP and FMT, and cautious growth expectations. The steady demand outlook and lack of significant inflection, coupled with unclear management responses, suggest a neutral impact on stock price.
Key Financial Performance
Organic orders growth in HST segment 34% year-over-year increase, driven by demand in data center construction, semiconductor filtration, sealing consumables, space and defense applications, and food and pharma markets.
Organic sales growth in HST segment 5% year-over-year increase, attributed to volume increases in data center applications, semiconductor consumables, and space and defense, partially offset by declines in life sciences, pharma, and general industrial.
Margin improvement in HST segment 60 basis points year-over-year increase, due to positive price cost, productivity gains, and operational excellence standards.
Organic orders growth in FMT segment 4% year-over-year increase, supported by municipal water businesses and mining through ABEL franchise, offset by softness in chemical, energy, and agriculture markets.
Organic sales growth in FMT segment 1% year-over-year increase, attributed to strength in municipal water businesses and mining, with noticeable softness in chemical, energy, and agriculture markets.
Adjusted EBITDA margin in FMT segment 20 basis points year-over-year decline, due to volume deleverage, higher employee-related costs, and unfavorable mix, despite positive price cost and cost containment actions.
Organic orders in FSDP segment Flat year-over-year, with growth in North American Fire & Rescue offset by pressures outside the U.S. and cyclical softness in dispensing.
Organic sales in FSDP segment 5% year-over-year decline, attributed to continued weakness in fire and safety outside the U.S. and subdued capital spending in dispensing.
Adjusted EBITDA margin in FSDP segment 50 basis points year-over-year increase, due to productivity gains and favorable mix, despite volume deleverage.
Free cash flow for 2025 $617 million, a 2% year-over-year increase, with a free cash flow conversion of 103% of adjusted net income, attributed to platform optimization and cost containment efforts.
Share repurchases in 2025 Nearly $250 million or 1.4 million shares repurchased, reflecting a disciplined approach to capital allocation.
You have reached the limit. Sign up to access full content
Get started
Operating Highlights
HST segment growth: Organic orders grew 34% in Q4 2025, driven by demand in data center construction, semiconductor consumables, and space and defense applications. Organic sales grew 5%.
Micro-LAM acquisition: Acquired Micro-LAM, enhancing Optics toolbox with proprietary forming capabilities. Integration is progressing well, and the business is largely booked for 2026.
Data center ecosystem: Strong growth in data center-related applications, including thermal management, liquid cooling, and power generation, driven by AI demand.
Municipal water and mining: Growth in municipal water businesses and mining through ABEL franchise due to increased demand for precious metals.
8020 playbook: Implemented to drive growth and margin expansion through resource allocation and segmentation.
Operational efficiencies: Achieved $60 million in savings in 2025 through platform optimization and cost containment.
Capital allocation strategy: Focused on maintaining a strong balance sheet, organic investments, M&A, and returning capital to shareholders.
Phase III evolution: Expanding capabilities in targeted markets through organic growth and M&A, supported by the 8020 playbook.
You have reached the limit. Sign up to access full content
Get started
Risk or Challenges
Macroeconomic Uncertainties: Continued challenges due to macroeconomic uncertainties impacting business performance and visibility.
Industrial Market Demand: General industrial landscape remains flat with no meaningful signs of demand improvement, particularly in industrial and auto market exposures within HST.
Chemical, Energy, and Agriculture Markets: Noticeable softness in chemical, energy, and agriculture markets, which make up over one-third of FMT.
Fire & Safety/Diversified Products Segment: Weakness in fire and safety markets outside the U.S. and subdued capital spending in dispensing.
Volume Deleveraging: Volume declines in FMT and FSDP segments, leading to margin pressures despite productivity gains.
Life Sciences and Pharma Markets: Year-over-year declines in life sciences and pharma markets within HST.
Geopolitical and Regional Pressures: Pressures outside the U.S. affecting the Fire & Rescue business.
Seasonal and Cyclical Factors: Seasonal softness in agricultural and water businesses during winter, and cyclical softness in dispensing.
You have reached the limit. Sign up to access full content
Get started
Guidance & Outlook
Organic Growth: For 2026, IDEX expects organic growth of 1% to 2%, with mid-single-digit growth for the Health & Science Technologies (HST) segment and flat to slightly down outlooks for Fluid & Metering Technologies (FMT) and Fire & Safety/Diversified Products (FSDP).
Adjusted EBITDA Margin: The adjusted EBITDA margin is projected to be in the range of 26.5% to 27% for 2026, with HST expected to achieve a 50 basis point improvement.
Adjusted EPS: The adjusted EPS guidance for 2026 is $8.15 to $8.35, representing low to mid-single-digit growth year-over-year.
First Quarter 2026 Guidance: For Q1 2026, IDEX expects organic growth of approximately 1%, adjusted EBITDA margin of approximately 24.5%, and adjusted EPS of $1.73 to $1.78, relatively flat year-over-year.
Market Trends and Segment Performance: HST is expected to see growth in data center applications, semiconductor consumables, and space and defense markets. FMT and FSDP are anticipated to remain flat or slightly down, with no significant inflection in demand observed in industrial order rates.
Capital Deployment: IDEX plans to focus on tuck-in acquisitions and returning capital to shareholders, similar to 2025. The company will maintain a balanced capital deployment plan.
You have reached the limit. Sign up to access full content
Get started
Shareholder Return Plan
Dividends Paid in 2025: $213 million
Dividend Target: 30% to 35% of adjusted net income paid remains unchanged
Share Repurchases in Q4 2025: $73 million
Total Share Repurchases in 2025: Nearly $250 million or 1.4 million shares
Share Repurchase Strategy: Base amount of repurchase consistently returned to shareholders, with flexibility based on leverage levels and relative M&A activity
You have reached the limit. Sign up to access full content
Get started
Key Q&A
Q:What is the current demand outlook based on day rates and order sizes?
A:The demand outlook is steady but has not yet shown an inflection. Businesses close to consumption have been steady through January, but no significant upward movement has been observed. Weather conditions in January may have impacted demand, and the company is monitoring February and March for changes.
Q:What are Sean Gillen's initial observations and priorities as the new CFO?
A:Sean Gillen noted IDEX's strong franchise, financial characteristics, and opportunities for capital allocation to drive growth. He aims to continue existing strategies while contributing to M&A strategy and execution, leveraging his past experience to enhance the company's performance.
Q:How much did price contribute to the top line in 2025, and what is the expected contribution for 2026?
A:In 2025, price contributed around 3% to the top line, with Q4 seeing a slightly higher contribution of 3.5%. For 2026, the company forecasts a price contribution of 1% to 2%.
Q:What is the volume trend across the portfolio, and how does it vary by segment?
A:Volumes are roughly flat overall, with positive volumes in HST and negative volumes in FSDP and FMT.
Q:What is the company's approach to capital allocation and potential portfolio pruning?
A:The company is focused on capitalizing on growth within acquired businesses and growth platforms. There are no immediate plans for significant divestitures, with any pruning being limited to smaller units or product lines.
Q:What is causing the disconnect between order strength and revenue conversion, and when is normalization expected?
A:The disconnect is due to weather impacts on FMT and larger orders in HST with longer lead times. Normalization is expected as these dynamics play out, with some revenue moving into Q2.
Q:What is the outlook for the life sciences segment in 2026?
A:The life sciences segment is expected to grow at low single digits, driven by pharma applications. Academic research remains pressured, and there is uncertainty around NIH funding and the impact of the government shutdown.
Q:How does the 2026 guidance compare to 2025 in terms of Q1 and Q4 progression?
A:The 2026 guidance shows stronger order support and backlog compared to 2025, particularly in HST, which has built over $100 million in backlog year-over-year.
Q:What is the potential growth in the data center power market, and what is the capital intensity for IDEX?
A:The data center power market has significant growth potential, with IDEX managing multiple applications across segments. The capital intensity is low, as existing equipment can handle increased production with minimal additional investment.
Q:What are the geographic trends in order activity?
A:India is leading in order activity, followed by North America and Europe. European chemicals remain pressured, while India shows strong growth.
Q:What is the company's strategy for platforming and growth in 2026?
A:The strategy focuses on leveraging cross-business collaboration and innovation to drive growth in advantaged markets. Platforms like water and data centers are key areas of focus, with no additional cost takeout actions planned for 2026.
Q:What is the company's approach to share repurchases in 2026?
A:The company plans to continue share repurchases at a rate of approximately $75 million per quarter, subject to M&A activity.
Q:What are the drivers of lithography and semiconductor growth?
A:Growth is driven by demand for advanced AI and memory chips for data centers. Trade restrictions have impacted some areas, but overall momentum is positive.
Q:What is the pricing power in the data center market, and how does it impact margins?
A:Pricing power in the data center market is consistent with other IDEX businesses, with critical components being low on the bill of materials. Margins are expected to remain strong as the business scales.
Q:What are the trends in municipal and industrial water markets?
A:Municipal water markets showed double-digit growth in Q4, driven by inspection and analytics work. The company expects mid-single-digit growth going forward, supported by infrastructure refurbishment and high-purity water applications for semiconductors.
Q:What is the impact of the platforming strategy on HST and FMT?
A:The platforming strategy has diversified HST, with growth in pneumatics, data centers, and MSS. FMT remains broadly industrial, with water growth offsetting pressures in chemicals and agriculture.
Q:Review of Unclear Management Responses
A:Management avoided providing specific details on the potential size of the data center power market in the next 1-2 years, citing it as an open question. Additionally, they did not provide clarity on the exact impact of AI-related orders within the HST segment, making it difficult to quantify its contribution to growth.
You have reached the limit. Sign up to access full content
Get started
Earnings Word Cloud
The most frequently occurring keywords in this quarter's earning call
BAND
FSDP margin
FSDP order
HST FSDP
HST order
HST segment
Technologies
business return
capital allocation
capital dividend
consumables space
cost productivity
deleverage mix
deployment methodology
dividend share
effort
enterprise Sean
flattish
food pharma
gain mix
improvement HST
market exposure
mix margin
nature business
order book
pharma space
playbook
productivity gain
share repurchase
softness chemical
specialty
strength
surface
visibility
volume deleverage
IEX Transcript
IDEX Corporation (IEX) Q4 2025 Earnings Call Transcript
Unknown2-4
The earnings call presents a mixed outlook. While there is strong performance in HST and optimistic guidance for 2026, there are concerns about flat volumes, pressures in FSDP and FMT, and cautious growth expectations. The steady demand outlook and lack of significant inflection, coupled with unclear management responses, suggest a neutral impact on stock price.
IDEX Corporation (IEX) Q3 2025 Earnings Call Transcript
Unknown10-29
The earnings call presents a mixed picture with a negative tilt. While the company has opportunities for growth and cost reduction, the reduction in revenue growth and EPS guidance, along with hesitancy in large orders, suggests challenges ahead. The Q&A reveals stable but fragmented business conditions, with some markets impacted by government funding changes. Despite positive M&A and capital allocation strategies, the overall sentiment is cautious, leading to a likely negative stock price movement.
IDEX Corporation (IEX) Q2 2025 Earnings Call Transcript
Unknown7-30
The earnings call summary presents a mixed picture. The basic financial performance and product development updates are neutral due to stable but not outstanding growth metrics. Market strategy and shareholder return plans are positive with strategic acquisitions and cost savings. However, expenses and financial health are concerning, with tariff impacts and margin pressure. The Q&A reveals some optimism about recovery and growth, but also highlights uncertainties like geopolitical tensions and decision-making delays. With no strong catalysts or negative surprises, the overall sentiment remains neutral, indicating minimal stock price movement.
IDEX Corporation (IEX) Q1 2025 Earnings Call Transcript
Unknown5-2
The earnings call presents a mixed picture. While there are positive elements such as a share repurchase program, better-than-expected sales, and a strong backlog, there are also concerns about customer hesitancy, sector-specific headwinds, and economic uncertainty. The Q&A section highlights some positive strategic positioning but also reveals management's avoidance of direct answers on key issues. The overall sentiment is balanced by these factors, leading to a neutral prediction for the stock price movement over the next two weeks.
IEX Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
